|
Vol 47 No. 3: 192-198 |
[PDF] [Full Text] |
|
The water network in galectin-3 ligand binding site guides inhibitor design |
|
Jiyong Su,
Tao Zhang,
Peiqi Wang,
Fengjian Liu,
Guihua Tai and
Yifa Zhou*
|
|
School of Life Sciences, Northeast Normal University, Changchun 130024, China |
|
Abstract Galectin-3 (Gal-3) which shows affinity of β-galactosides is a cancer-related protein. Thus, it is important to understand its ligand binding mechanism and then design its specific inhibitor. It was suggested that the positions of water molecules in Gal-3 ligand-binding site could be replaced by appropriate chemical groups of ideal inhibitors. However, the reported structures of Gal-3 carbohydrate recognition domain (CRD) complexed with lactose showed that the number of water molecules are different and the water positions are inconsistent in the ligand-binding site. This study reported four high-resolution (1.24�C1.19 Å) structures of Gal-3 CRD complexed with lactose, and accurately located 12 conserved water molecules in the water network of Gal-3 CRD ligand-binding site by merging these structures. These water molecules either directly stabilize the binding of Gal-3 CRD and lactose, or hold the former water molecules at the right place. In particular, water molecule 4 (W4) which only coordinates with water molecule 5 (W5) and water molecule 6 (W6) plays a key role in stabilizing galactose residue. In addition, by three-dimensional alignment of the positions of all residues, 14 flexible parts of Gal-3 CRD were found to dynamically fluctuate in the crystalline environment.
|
|
Keywords co-crystal structure; galectin-3; lactose; water molecule; drug design
|
|
Received 2014-9-20
Accepted 2014-12-26
|
|
Funding Galectin-3 (Gal-3) which shows affinity of β-galactosides is a cancer-related protein. Thus, it is important to understand its ligand binding mechanism and then design its specific inhibitor. It was suggested that the positions of water molecules in Gal-3
|
|
* Correspondence address Tel/Fax: +86-431-85098212; E-mail: [email protected]
|
|
Browse:183 |